Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Jones

Showing results (421-430 of 459) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantationY Nieto, P J Cagnoni, S Nawaz, et al.
Journal of Hematotherapy|December 1, 1995
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantationM H Purdy, C J Hogan, L Hami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftmentE J Shpall, R B Jones, S I Bearman, et al.
Journal of Clinical Microbiology|December 2, 2000
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic menR E Johnson, T A Green, J Schachter, et al.
Bone Marrow Transplantation|May 30, 2003
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemiaB C Medeiros, J F Kolhouse, P J Cagnoni, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Journal of Clinical Microbiology|March 4, 2000
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatisB Van Der Pol, T C Quinn, C A Gaydos, et al.
Pageof 46

Showing results (421-430 of 459) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantationY Nieto, P J Cagnoni, S Nawaz, et al.
Journal of Hematotherapy|December 1, 1995
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantationM H Purdy, C J Hogan, L Hami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftmentE J Shpall, R B Jones, S I Bearman, et al.
Journal of Clinical Microbiology|December 2, 2000
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic menR E Johnson, T A Green, J Schachter, et al.
Bone Marrow Transplantation|May 30, 2003
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemiaB C Medeiros, J F Kolhouse, P J Cagnoni, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Journal of Clinical Microbiology|March 4, 2000
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatisB Van Der Pol, T C Quinn, C A Gaydos, et al.
Pageof 46